{"transactions":[{"id":892716,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-20T01:57:23.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":45559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":321109,"source":{"system":"sec-edgar","filing":"0001570562-26-000022","document":"wk-form4_1771552641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056226000022/wk-form4_1771552641.xml","form_type":"4"}},{"id":1211617,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T22:53:27.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":11146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":11146,"derivative":{"exercise_price":13.58,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":11146},"source":{"system":"sec-edgar","filing":"0001570562-25-000036","document":"wk-form4_1741733600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000036/wk-form4_1741733600.xml","form_type":"4"}},{"id":1211616,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-11T22:53:27.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":7364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":253878,"source":{"system":"sec-edgar","filing":"0001570562-25-000036","document":"wk-form4_1741733600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056225000036/wk-form4_1741733600.xml","form_type":"4"}},{"id":1489503,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T01:30:56.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":12.9604,"value":97203.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $12.9602 to $12.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":246514,"source":{"system":"sec-edgar","filing":"0001570562-24-000093","document":"wk-form4_1717637447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000093/wk-form4_1717637447.xml","form_type":"4"}},{"id":1515622,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T21:19:49.000Z","date":"2024-05-13","kind":"sale","planned":false,"acquired":false,"shares":28000,"price":12.929,"value":362012.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $12.92 to $12.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":254014,"source":{"system":"sec-edgar","filing":"0001570562-24-000089","document":"wk-form4_1715807976.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000089/wk-form4_1715807976.xml","form_type":"4"}},{"id":1651241,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-09T23:37:00.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":9377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":9377,"derivative":{"exercise_price":13.15,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":9377},"source":{"system":"sec-edgar","filing":"0001570562-24-000020","document":"wk-form4_1707521811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000020/wk-form4_1707521811.xml","form_type":"4"}},{"id":1651240,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T23:37:00.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":6464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 7, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":282014,"source":{"system":"sec-edgar","filing":"0001570562-24-000020","document":"wk-form4_1707521811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056224000020/wk-form4_1707521811.xml","form_type":"4"}},{"id":1807014,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-15T20:34:15.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":174967,"price":7.41,"value":1296505.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the private transfer of shares of common stock of the issuer from Strathspey Crown Holdings Group, LLC  (\"SCH\") to the reporting person, who elected to receive payment of certain outstanding fees from SCH in the form of shares of common stock of the issuer held by SCH rather than cash."}],"balance_after":275550,"source":{"system":"sec-edgar","filing":"0001570562-23-000094","document":"wk-form4_1692131636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000094/wk-form4_1692131636.xml","form_type":"4"}},{"id":1807013,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-15T20:34:15.000Z","date":"2023-08-11","kind":"other","planned":false,"acquired":true,"shares":22998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Alphaeon 1, LLC of which the reporting person is a non-managing member."}],"balance_after":100583,"source":{"system":"sec-edgar","filing":"0001570562-23-000094","document":"wk-form4_1692131636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000094/wk-form4_1692131636.xml","form_type":"4"}},{"id":1822966,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":77453,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"At the Effective Time, each outstanding award of restricted stock unit (\"RSU\") representing the contingent right to receive shares of AEON common stock (each an \"AEON RSU\") was automatically cancelled and converted into an RSU representing the contingent right to receive a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON RSU multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"shares","element":"transactionShares","label":"F14","text":"At the Effective Time, each outstanding award of restricted stock unit (\"RSU\") representing the contingent right to receive shares of AEON common stock (each an \"AEON RSU\") was automatically cancelled and converted into an RSU representing the contingent right to receive a number of shares of common stock of the Issuer equal to (i) the number of shares of AEON common stock subject to the applicable AEON RSU multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"shares","element":"transactionShares","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"Represents an award of RSUs on April 26, 2023, which vests 6.25% vests upon the achievement of a first earnout goal, 25% upon the achievement of a second earnout goal, 25% upon the achievement of a third earnout, and 43.75% upon achievement of a fourth earnout goal. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":77453,"derivative":{"underlying":"Stock Options","underlying_shares":77453},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822965,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":7765,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F13","text":"Represents an award of stock options granted on March 9, 2022, which vests in three yearly installments from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents an award of stock options granted on March 9, 2022, which vests in three yearly installments from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":7765,"derivative":{"underlying":"Stock Options","underlying_shares":7765},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822964,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":21198,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":21198,"derivative":{"underlying":"Stock Options","underlying_shares":21198},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822963,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":19800,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents an award of stock options granted on March 5, 2021, which vested ratably over one year from March 5, 2021. Such options expire on March 5, 2031. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents an award of stock options granted on March 5, 2021, which vested ratably over one year from March 5, 2021. Such options expire on March 5, 2031. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":19800,"derivative":{"underlying":"Stock Options","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822962,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":21974,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents an award of stock options granted on August 5, 2020, which vested ratably over one year from March 4, 2020. Such options expire on August 1, 2030. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents an award of stock options granted on August 5, 2020, which vested ratably over one year from March 4, 2020. Such options expire on August 1, 2030. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":21974,"derivative":{"underlying":"Stock Options","underlying_shares":21974},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822961,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":38824,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":38824,"derivative":{"underlying":"Stock Options","underlying_shares":38824},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822960,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Options","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":38824,"ownership":{"direct":false,"nature":"Held by Oleg Grodnensky"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"At the Effective Time, each outstanding option to purchase shares of AEON common stock (each an \"AEON Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer at a per-share exercise price of $10 per share."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents an award of stock options granted on November 20, 2019, which vested in three yearly installments from November 1, 2019. Such options expire on November 20, 2029. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Represents an award of stock options granted on March 9, 2022, which vested ratably over one year from March 9, 2022. Such options expire on March 9, 2032. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":38824,"derivative":{"underlying":"Stock Options","underlying_shares":38824},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822959,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Private Placement Warrants","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":false,"shares":5280000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"(ii) the Private Placement Warrants will not be redeemable by the Issuer so long as they are held by the Sponsor, Priveterra's officers or directors, or its or their respective permitted transferees (except as set forth in the warrant agreement), (iii) the Private Placement Warrants may be exercised by the Sponsor, Priveterra's officers and directors, or its or their respective permitted transferees on a cashless basis, (iv) if the private placement warrants are held by holders other than the Sponsor, Priveterra's officers and directors, or its or their permitted transferees, the Private Placement Warrants will be redeemable by the Issuer and exercisable by the holders on the same basis as the public warrants; and (v) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) are entitled to registration rights."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5280000},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822958,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":false,"shares":6900000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"shares","element":"transactionShares","label":"F7","text":"The reporting person disposed of all Class B common stock upon the consummation of the Issuer's Initial Business Combination, which were automatically exchanged on a one-for-one basis into Class A common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Sponsor is the record holder of the securities reported herein. Messrs Grodnensky, Palmisano, and Malik are the managers of the Sponsor and share voting and investment discretion with respect to the securities held of record by the Sponsor."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6900000},"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822957,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":89163,"ownership":{"direct":false,"nature":"Held by Vikram Malik"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These securities, which were acquired upon the closing of the Initial Business Combination pursuant to the terms of the BCA as a result of the cancellation of the shares of Old AEON (\"Old AEON Common Stock\") held by Mr. Malik and Sabina Taneja and the automatic conversion of such shares into 2.328 (the \"Exchange Ratio\") shares of Class A common stock of the Issuer, are held directly by Mr. Malik, a manager of the Sponsor, and Ms. Taneja. The Sponsor disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein."}],"balance_after":6989163,"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":1822956,"issuer":{"id":7859,"kind":"organization","name":"AEON Biopharma, Inc."},"owners":[{"id":111134,"kind":"organization","name":"Priveterra Sponsor, LLC","position":1,"cik":"0001843128","reported_name":"Priveterra Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111135,"kind":"person","name":"Grodnensky Oleg","position":2,"cik":"0001843167","reported_name":"Grodnensky Oleg","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36462,"kind":"person","name":"PALMISANO ROBERT J","position":3,"cik":"0001138646","reported_name":"PALMISANO ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":65622,"kind":"person","name":"Malik Vikram","position":4,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-26T21:06:50.000Z","date":"2023-07-21","kind":"exercise","planned":false,"acquired":true,"shares":6900000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Priveterra Acquisition Corp. (\"Priveterra\") Class B common stock were cancelled and, in exchange, the holder(s) thereof was entitled to receive Class A common stock of the Issuer on a one-for-one basis upon the consummation of the Issuer's initial business combination on July 21, 2023 pursuant to that certain Business Combination Agreement (the \"BCA\"), dated as of December 12, 2022, as amended April 27, 2023, by and among the Issuer, Priveterra Merger Sub, Inc. (\"Merger Sub\") and AEON Biopharma, Inc. (\"Old AEON\") (the \"Initial Business Combination\"). 2,070,000 of the shares of Class A common stock of the Issuer held by Priveterra Sponsor, LLC. (the \"Sponsor\") are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"1,380,000 of the shares of Class A common stock of the Issuer held by the Sponsor vest based on the achievement of certain pre-established share price targets and the remaining 3,450,000 shares of Class A common stock of the Issuer held by the Sponsor will vest based on the achievement of certain milestones, each as set forth in Amendment No.1 to the Sponsor Support Agreement, dated as of April 27, 2023. Simultaneously with the Issuer's initial public offering (\"IPO\"), the Sponsor acquired 5,213,333 warrants of the Issuer exercisable to purchase one share of Class A common stock of the Issuer at an exercise price of $11.50 per share (the \"Private Placement Warrants\") and Sponsor subsequently acquired 66,667 Private Placement Warrants on June 28, 2021 upon the conversion of an unsecured convertible promissory note issued by the Issuer to the Sponsor on February 15, 2021."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As described in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) filed with the Securities and Exchange Commission on January 21, 2021, the Private Placement Warrants are identical to the warrants sold in connection with the Issuer's IPO, except that (i) the Private Placement Warrants (including shares of Class A common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Initial Business Combination (except, among other limited exceptions, to Priveterra's officers and directors, the Sponsor, or any of its or their respective permitted transferees);"}],"balance_after":6900000,"source":{"system":"sec-edgar","filing":"0000950103-23-010810","document":"dp197251_4-psllc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138646/000095010323010810/dp197251_4-psllc.xml","form_type":"4"}},{"id":2039982,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T01:42:04.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":11789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":11789,"derivative":{"exercise_price":10.25,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":11789},"source":{"system":"sec-edgar","filing":"0001570562-23-000024","document":"wf-form4_167521570855640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000024/wf-form4_167521570855640.xml","form_type":"4"}},{"id":2039981,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T01:42:04.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":8293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":77585,"source":{"system":"sec-edgar","filing":"0001570562-23-000024","document":"wf-form4_167521570855640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056223000024/wf-form4_167521570855640.xml","form_type":"4"}},{"id":2424954,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T02:02:14.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":22727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":22727,"derivative":{"exercise_price":5.46,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":22727},"source":{"system":"sec-edgar","filing":"0001570562-22-000051","document":"wf-form4_164324891686588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056222000051/wf-form4_164324891686588.xml","form_type":"4"}},{"id":2424953,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T02:02:14.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":15568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer"}],"balance_after":69292,"source":{"system":"sec-edgar","filing":"0001570562-22-000051","document":"wf-form4_164324891686588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056222000051/wf-form4_164324891686588.xml","form_type":"4"}},{"id":2590513,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T22:37:57.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":26077,"price":10.9952,"value":286721.8304,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold by Strathspey Crown Holdings Group, LLC (\"SCH\") in multiple trades at prices ranging from $10.82 to $11.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1143701,"source":{"system":"sec-edgar","filing":"0001570562-21-000167","document":"wf-form4_162993106421148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000167/wf-form4_162993106421148.xml","form_type":"4"}},{"id":2594500,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-21T00:19:52.000Z","date":"2021-08-20","kind":"sale","acquired":false,"shares":49878,"price":10.6122,"value":529315.3116,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold by SCH in multiple trades at prices ranging from $10.34 to $10.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1169778,"source":{"system":"sec-edgar","filing":"0001570562-21-000165","document":"wf-form4_162950516202272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000165/wf-form4_162950516202272.xml","form_type":"4"}},{"id":2594499,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-21T00:19:52.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":11962,"price":10.4962,"value":125555.5444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold by Strathspey Crown Holdings Group, LLC (\"SCH\") in multiple trades at prices ranging from $10.47 to $10.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1219656,"source":{"system":"sec-edgar","filing":"0001570562-21-000165","document":"wf-form4_162950516202272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000165/wf-form4_162950516202272.xml","form_type":"4"}},{"id":2595856,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T23:01:00.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":25000,"price":10.4405,"value":261012.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold by SCH in multiple trades at prices ranging from $9.92 to $10.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1231618,"source":{"system":"sec-edgar","filing":"0001570562-21-000163","document":"wf-form4_162941403051387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000163/wf-form4_162941403051387.xml","form_type":"4"}},{"id":2595855,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T23:01:00.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":42083,"price":10.0646,"value":423548.5618,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold by Strathspey Crown Holdings Group, LLC (\"SCH\") in multiple trades at prices ranging from $9.90 to $10.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1256618,"source":{"system":"sec-edgar","filing":"0001570562-21-000163","document":"wf-form4_162941403051387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000163/wf-form4_162941403051387.xml","form_type":"4"}},{"id":2770274,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-26T23:05:16.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":18011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 26, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":53724,"source":{"system":"sec-edgar","filing":"0001570562-21-000108","document":"wf-form4_161679989764970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000108/wf-form4_161679989764970.xml","form_type":"4"}},{"id":2871247,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-09T22:13:47.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":19313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 5, 2021, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer."}],"balance_after":35713,"source":{"system":"sec-edgar","filing":"0001570562-21-000039","document":"wf-form4_161290881141578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056221000039/wf-form4_161290881141578.xml","form_type":"4"}},{"id":3302454,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-25T02:07:09.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":23458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":23458,"derivative":{"exercise_price":10.19,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":23458},"source":{"system":"sec-edgar","filing":"0001570562-20-000036","document":"wf-form4_157991801048284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056220000036/wf-form4_157991801048284.xml","form_type":"4"}},{"id":3501760,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T23:52:55.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":1298701,"price":19.25,"value":24999994.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation (\"ALPHAEON\")  and Strathspey Crown Holdings Group, LLC (\"SCH\"). SCH is the majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed \"restricted securities\" under Rule 144 promulgated under the Securities Act of 1933, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose"}],"balance_after":1298701,"source":{"system":"sec-edgar","filing":"0001570562-19-000095","document":"wf-form4_155969235978393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056219000095/wf-form4_155969235978393.xml","form_type":"4"}},{"id":3686495,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-26T01:17:01.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer."}],"balance_after":14500,"derivative":{"exercise_price":16.19,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001570562-19-000017","document":"wf-form4_154846540438935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056219000017/wf-form4_154846540438935.xml","form_type":"4"}},{"id":3728772,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T02:50:59.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":7800,"price":13.037,"value":101688.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $12.92 to $13.07. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16400,"source":{"system":"sec-edgar","filing":"0001570562-18-000129","document":"wf-form4_154510144090151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056218000129/wf-form4_154510144090151.xml","form_type":"4"}},{"id":3892056,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T20:27:28.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":8600,"price":28.8783,"value":248353.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $28.83 to $28.8993. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8600,"source":{"system":"sec-edgar","filing":"0001570562-18-000057","document":"wf-form4_152909443160111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056218000057/wf-form4_152909443160111.xml","form_type":"4"}},{"id":3955950,"issuer":{"id":5341,"kind":"organization","name":"Evolus, Inc.","symbol":"EOLS"},"owners":[{"id":65622,"kind":"person","name":"Malik Vikram","position":1,"cik":"0001730123","reported_name":"Malik Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-26T17:37:33.000Z","date":"2018-04-24","kind":"grant","acquired":true,"shares":9086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of January 6, 2018."}],"balance_after":9086,"derivative":{"exercise_price":8.01,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":9086},"source":{"system":"sec-edgar","filing":"0001570562-18-000024","document":"wf-form4_152476423933800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1570562/000157056218000024/wf-form4_152476423933800.xml","form_type":"4"}}]}